Stay updated on Pembrolizumab in Kaposi's Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the study record for a Phase II pembrolizumab trial for classic or endemic Kaposi’s sarcoma, including its design, eligibility criteria, contacts, and outcome measures.
    Difference
    52%
    Check dated 2026-11-08T13:30:20.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T14:38:41.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A ClinicalTrials.gov page shell is shown instead of the prior 403 error, along with a notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    2%
    Check dated 2026-10-25T15:32:30.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2 while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T22:07:31.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer's revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:01:49.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content with a basic error screen. A Home link and standard footer appear, indicating the page is currently inaccessible.
    Difference
    19%
    Check dated 2026-09-20T20:47:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Kaposi's Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.